S&P 500   3,333.69 (-0.80%)
DOW   27,686.91 (-0.38%)
QQQ   266.09 (-1.56%)
AAPL   437.50 (-2.97%)
MSFT   204.05 (-2.02%)
FB   256.13 (-2.61%)
GOOGL   1,480.54 (-1.09%)
AMZN   3,080.67 (-2.14%)
NVDA   435.81 (-2.42%)
CGC   16.95 (-5.47%)
BABA   248.42 (+0.12%)
TSLA   1,376.17 (-2.99%)
GE   6.73 (+0.90%)
MU   47.76 (-2.83%)
AMD   76.88 (-6.52%)
T   30.20 (-0.03%)
F   7.23 (+1.97%)
ACB   10.02 (-1.96%)
GILD   68.10 (-0.60%)
NFLX   467.50 (-3.29%)
DIS   130.49 (+1.32%)
BAC   26.92 (+1.36%)
BA   180.13 (+0.40%)
S&P 500   3,333.69 (-0.80%)
DOW   27,686.91 (-0.38%)
QQQ   266.09 (-1.56%)
AAPL   437.50 (-2.97%)
MSFT   204.05 (-2.02%)
FB   256.13 (-2.61%)
GOOGL   1,480.54 (-1.09%)
AMZN   3,080.67 (-2.14%)
NVDA   435.81 (-2.42%)
CGC   16.95 (-5.47%)
BABA   248.42 (+0.12%)
TSLA   1,376.17 (-2.99%)
GE   6.73 (+0.90%)
MU   47.76 (-2.83%)
AMD   76.88 (-6.52%)
T   30.20 (-0.03%)
F   7.23 (+1.97%)
ACB   10.02 (-1.96%)
GILD   68.10 (-0.60%)
NFLX   467.50 (-3.29%)
DIS   130.49 (+1.32%)
BAC   26.92 (+1.36%)
BA   180.13 (+0.40%)
S&P 500   3,333.69 (-0.80%)
DOW   27,686.91 (-0.38%)
QQQ   266.09 (-1.56%)
AAPL   437.50 (-2.97%)
MSFT   204.05 (-2.02%)
FB   256.13 (-2.61%)
GOOGL   1,480.54 (-1.09%)
AMZN   3,080.67 (-2.14%)
NVDA   435.81 (-2.42%)
CGC   16.95 (-5.47%)
BABA   248.42 (+0.12%)
TSLA   1,376.17 (-2.99%)
GE   6.73 (+0.90%)
MU   47.76 (-2.83%)
AMD   76.88 (-6.52%)
T   30.20 (-0.03%)
F   7.23 (+1.97%)
ACB   10.02 (-1.96%)
GILD   68.10 (-0.60%)
NFLX   467.50 (-3.29%)
DIS   130.49 (+1.32%)
BAC   26.92 (+1.36%)
BA   180.13 (+0.40%)
S&P 500   3,333.69 (-0.80%)
DOW   27,686.91 (-0.38%)
QQQ   266.09 (-1.56%)
AAPL   437.50 (-2.97%)
MSFT   204.05 (-2.02%)
FB   256.13 (-2.61%)
GOOGL   1,480.54 (-1.09%)
AMZN   3,080.67 (-2.14%)
NVDA   435.81 (-2.42%)
CGC   16.95 (-5.47%)
BABA   248.42 (+0.12%)
TSLA   1,376.17 (-2.99%)
GE   6.73 (+0.90%)
MU   47.76 (-2.83%)
AMD   76.88 (-6.52%)
T   30.20 (-0.03%)
F   7.23 (+1.97%)
ACB   10.02 (-1.96%)
GILD   68.10 (-0.60%)
NFLX   467.50 (-3.29%)
DIS   130.49 (+1.32%)
BAC   26.92 (+1.36%)
BA   180.13 (+0.40%)
Log in

OTCMKTS:PSIDPositiveID Stock Price, Forecast & News

$0.0001
0.00 (0.00 %)
(As of 03/26/2020)
Add
Compare
Today's Range
$0.00
Now: $0.00
$0.00
50-Day Range N/A
52-Week Range
$0.00
Now: $0.00
$0.00
Volume32.70 million shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
PositiveID Corporation, a life sciences and technology company, develops and sells molecular diagnostic systems for bio-threat detection and medical testing in the United States and internationally. It operates through three segments: Molecular Diagnostics, Medical Devices, and Mobile Labs. The company develops microfluidic systems for the automated preparation and performance of biological assays to detect biological threats and analyze biological samples at the point of need. It has a portfolio of intellectual property related to sample preparation and rapid medical testing applications. The company's microfluidic bio-agent autonomous networked detector (M-BAND) technology is a bio-aerosol monitor with integrated systems for sample collection, processing, and detection modules. Its M-BAND technology analyzes air samples for the detection of pathogenic bacteria, viruses, and toxins for up to 30 days. The company's FireflyDX is an automated pathogen detection system for rapid diagnostics for clinical and point-of-need applications. Its FireflyDX system detects and identifies common pathogens and diseases, such as E. coli, methicillin-resistant staphylococcus aureus, methicillin-susceptible staphylococcus aureus, clostridium difficile, Zika virus, Ebola virus, influenza, and others. In addition, PositiveID Corporation markets Caregiver, a non-contact clinical thermometer that measures forehead temperature in adults, children, and infants for hospitals, physicians' offices, medical clinics, nursing homes and other long-term care institutions, and acute care hospitals; and manufactures and sells specialty technology vehicles for mobile laboratory, command and communications applications, and mobile cellular systems. The company was formerly known as VeriChip Corporation and changed its name to PositiveID Corporation in November 2009. PositiveID Corporation was founded in 2001 and is headquartered in Delray Beach, Florida.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.70 out of 5 stars


Industry, Sector and Symbol

Industry Analytical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:PSID
CUSIPN/A
Phone561-805-8000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$5.36 million

Profitability

Miscellaneous

Employees30
Next Earnings DateN/A
OptionableNot Optionable
$0.0001
0.00 (0.00 %)
(As of 03/26/2020)
30 days | 90 days | 365 days | Advanced Chart

Receive PSID News and Ratings via Email

Sign-up to receive the latest news and ratings for PSID and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











PositiveID (OTCMKTS:PSID) Frequently Asked Questions

How has PositiveID's stock been impacted by Coronavirus?

PositiveID's stock was trading at $0.0002 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, PSID shares have decreased by 50.0% and is now trading at $0.0001.
View which stocks have been most impacted by COVID-19
.

Has PositiveID been receiving favorable news coverage?

News headlines about PSID stock have trended neutral this week, InfoTrie reports. The research firm identifies negative and positive news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. PositiveID earned a news sentiment score of 0.2 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next few days.
View the latest news about PositiveID
.

Are investors shorting PositiveID?

PositiveID saw a increase in short interest in the month of February. As of February 15th, there was short interest totaling 997,000 shares, an increase of 996,900.0% from the January 31st total of 100 shares. Based on an average daily volume of 11,567,300 shares, the days-to-cover ratio is presently 0.1 days.
View PositiveID's Short Interest
.

Who are some of PositiveID's key competitors?

What other stocks do shareholders of PositiveID own?

Based on aggregate information from My MarketBeat watchlists, some companies that other PositiveID investors own include Vuzix (VUZI), Marijuana Company Of America (MCOA), Bridgeline Digital (BLIN), InterCloud Systems (ICLD), Inpixon (INPX), Dicks Sporting Goods (DKS), Precipio (PRPO), Amarin (AMRN), Biocept (BIOC) and Healthequity (HQY).

Who are PositiveID's key executives?

PositiveID's management team includes the following people:
  • Mr. William J. Caragol, Chairman, CEO & Acting CFO (Age 52)
  • Mr. Gary J. O'Hara, Chief Technology Officer (Age 69)
  • Ms. Allison F. Tomek, Sr. VP of Corp. Devel. & Sec.
  • Dr. Kimothy Smith Ph.D., Chief Technology Advisor & Member of Advisory Board

What is PositiveID's stock symbol?

PositiveID trades on the OTCMKTS under the ticker symbol "PSID."

How do I buy shares of PositiveID?

Shares of PSID can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is PositiveID's stock price today?

One share of PSID stock can currently be purchased for approximately $0.00.

What is PositiveID's official website?

The official website for PositiveID is www.psidcorp.com.

How can I contact PositiveID?

PositiveID's mailing address is 1690 SOUTH CONGRESS AVENUE SUITE 201, DELRAY BEACH FL, 33445. The company can be reached via phone at 561-805-8000.

This page was last updated on 8/11/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.